Ascendis Pharma A/S (ASND)

CIK 1612042 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ascendis Pharma A/S.

Recent SEC filings

FiledFormAccession number
Sep 9, 202640001610717-26-000409
Sep 9, 20266-K0001193125-26-386630
Sep 9, 20266-K0001193125-26-386434
Sep 8, 20261440001964306-26-000432
Sep 3, 202640001610717-26-000395
Sep 2, 20261440001973379-26-000330
Aug 31, 20266-K0001193125-26-376733
Aug 18, 202640001610717-26-000360
Aug 13, 20266-K0001193125-26-348046
Aug 13, 20266-K0001612042-26-000016
Aug 13, 2026SCHEDULE 13G/A0001193125-26-349304
Aug 12, 20266-K0001193125-26-347172
Aug 6, 20266-K0001193125-26-337270
Jul 15, 20266-K0001193125-26-304903
Jun 30, 20266-K0001193125-26-290485
Jun 29, 20266-K0001193125-26-288414
Jun 17, 20266-K0001193125-26-274306
Jun 15, 20266-K0001193125-26-270227
Jun 12, 20266-K0001193125-26-268415
Jun 10, 20266-K0001193125-26-265829
Jun 2, 202640001610717-26-000179
Jun 1, 20263/A0001610717-26-000175
Jun 1, 202640001610717-26-000177
Jun 1, 202640001610717-26-000176
May 27, 202640001610717-26-000161